‘Beyond the scope and training of pharmacists’

6CPA Chronic Pain MedsCheck trial comes under GP criticism as it approaches MSAC assessment  The Royal Australian College of General Practitioners (RACGP) has widened its attack on pharmacy programs, saying it had 'serious concerns' about the Chronic Pain MedsCheck Trial   In its recent submission to the Medical Services Advisory Committee (MSAC) review of the trial,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous A well deserved award
Next World News Wrapup: 23 June 2022